Conexeu Sciences Inc. (NASDAQ:CNXU) Short Interest Up 56.4% in August

Key Points

• Short interest increased 56.4% in August to 202,485 shares, representing 0.8% of shares outstanding and a days-to-cover ratio of 0.6.
• Analyst sentiment is mixed, with one Buy, one Hold, and one Sell rating; the consensus rating is Hold with a $20.00 average price target.
• Conexeu shares opened at $5.13, well below the $7.76 50-day moving average, while the company reported a quarterly loss of $0.29 per share—$0.19 worse than estimates.

Conexeu Sciences Inc. (NASDAQ:CNXU - Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 202,485 shares, a growth of 56.4% from the August 15th total of 129,461 shares. Based on an average daily volume of 321,266 shares, the days-to-cover ratio is presently 0.6 days. Currently, 0.8% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Weiss Ratings assumed coverage on shares of Conexeu Sciences in a research report on Monday, August 17th. They issued a "sell (e-)" rating for the company. Wall Street Zen upgraded Conexeu Sciences to a "hold" rating in a research report on Saturday, May 30th. HC Wainwright initiated coverage on Conexeu Sciences in a research report on Monday, June 22nd. They set a "buy" rating and a $20.00 target price for the company. Finally, Zacks Research raised Conexeu Sciences to a "hold" rating in a research note on Monday, June 29th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Conexeu Sciences currently has an average rating of "Hold" and an average price target of $20.00.

Conexeu Sciences Trading Up 15.4%

Shares of CNXU stock opened at $5.13 on Thursday. The company has a fifty day moving average price of $7.76. Conexeu Sciences has a one year low of $4.19 and a one year high of $18.79. The firm has a market capitalization of $144.86 million and a PE ratio of -46.52.

Conexeu Sciences (NASDAQ:CNXU - Get Free Report) last issued its earnings results on Monday, September 14th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). On average, research analysts expect that Conexeu Sciences will post -0.4 EPS for the current fiscal year.

Conexeu Sciences Company Profile

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.